What is the expected growth forecast for the market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the COVID-19 Rapid Antibody Test Kits market?

Key drivers include rising COVID-19 cases, advancements in technology, and growing awareness of rapid testing.

What challenges does the COVID-19 Rapid Antibody Test Kits market face?

Challenges include regulatory hurdles, competition from alternative tests, and supply chain disruptions.

Which regions are leading the COVID-19 Rapid Antibody Test Kits market?

North America and Europe are currently leading the market, driven by strong healthcare infrastructure.

Who are the top companies in the COVID-19 Rapid Antibody Test Kits market?

Top companies include Roche, Abbott, and Siemens, which offer a range of rapid antibody test kits.

What future opportunities exist in the COVID-19 Rapid Antibody Test Kits market?

Future opportunities include emerging markets, point-of-care testing, and integration with digital platforms.

How is technology impacting the COVID-19 Rapid Antibody Test Kits market?

Technology is enabling faster, more accurate testing, and improving connectivity between healthcare providers and patients.

What is the current regulatory landscape for the COVID-19 Rapid Antibody Test Kits market?

The regulatory landscape is evolving, with ongoing updates to guidelines and standards for rapid antibody test kits.

What is the future outlook for the COVID-19 Rapid Antibody Test Kits market?

The future outlook is positive, with growing demand and advancements in technology driving market growth.

COVID-19 Rapid Antibody Test Kits Market Metrics & Forecast Analysis 2033

COVID-19 Rapid Antibody Test Kits by Application (Hospital, Company, School, Home, Others), by Types (IgG Test, IgM Test, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $15590 million

CAGR: 21.7%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $15590 million

CAGR: 21.7%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

COVID-19 Rapid Antibody Test Kits Market Overview

The COVID-19 Rapid Antibody Test Kits market refers to the industry that produces and distributes rapid antibody test kits for the detection of COVID-19. As the world continues to grapple with the pandemic, the COVID-19 Rapid Antibody Test Kits market size is expected to experience significant growth outlook and market forecast, driven by increasing demand for rapid and accurate testing solutions, leading to substantial industry expansion. The scope of this market encompasses various types of rapid antibody test kits, including lateral flow assays and enzyme-linked immunosorbent assays (ELISA), which are used in different settings such as hospitals, clinics, and laboratories. According to recent estimates, the current COVID-19 Rapid Antibody Test Kits market size is approximately $3.4 billion, with a projected growth forecast of 10.2% Compound Annual Growth Rate (CAGR) from 2026 to 2033, driven by macro drivers such as advancements in technology and increasing government initiatives to combat the pandemic.

Loading chart…

The COVID-19 Rapid Antibody Test Kits market is shaped by several key forces, including technology shifts, such as the development of more accurate and rapid testing solutions, regulations, such as those related to the approval and distribution of test kits, and consumer behavior, such as the increasing demand for self-testing solutions. The largest region in the COVID-19 Rapid Antibody Test Kits market is currently North America, while the fastest-growing region is expected to be Asia-Pacific, driven by increasing government initiatives and investments in healthcare infrastructure. Overall, the COVID-19 Rapid Antibody Test Kits market is expected to experience significant growth and industry expansion in the coming years, driven by increasing demand for rapid and accurate testing solutions.

Report Overview

Report Attribute	Details
Market size value in 2025	15.59 billion
Revenue forecast in 2033	27.19 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	RayBiotech Life; Aurora Biomed; SD Biosensor; Abingdon Health; INSTI; CTK Biotech; SBL Testing Technologies; Biopanda; Roche Diagnostics; TestLine Clinical Diagnostics; Assay Genie; Nadal-test; Panodyne; Luminex
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The COVID-19 Rapid Antibody Test Kits market is experiencing significant fluctuations due to various market dynamics. Understanding these factors is crucial for stakeholders to navigate the market effectively and make informed decisions.

Growth Drivers2 items

Increasing demand for rapid diagnostic tests due to the ongoing COVID-19 pandemic is driving the growth of the COVID-19 Rapid Antibody Test Kits market size. This demand is further amplified by the need for timely and accurate diagnosis to contain the spread of the virus.

Advancements in technology have led to the development of more accurate and reliable COVID-19 Rapid Antibody Test Kits, which is contributing to the growth forecast of the market. These advancements include improved sensitivity, specificity, and ease of use, making the tests more appealing to both healthcare professionals and patients.

Restraints2 items

Stringent regulatory requirements and the need for emergency use authorizations are restraining the COVID-19 Rapid Antibody Test Kits market. Manufacturers must comply with these regulations, which can be time-consuming and costly, potentially limiting the availability of test kits.

The high cost of development and production of COVID-19 Rapid Antibody Test Kits is another restraint. This can make it challenging for new entrants to join the market and for existing players to maintain profitability, especially in price-sensitive regions.

Opportunities2 items

The COVID-19 Rapid Antibody Test Kits market presents opportunities for manufacturers to expand their product portfolios and reach new markets. This can be achieved through strategic partnerships, investments in research and development, and the exploration of new distribution channels.

The growing awareness of the importance of rapid diagnostic testing in controlling the spread of COVID-19 is creating new opportunities for the market. This awareness is driving demand for COVID-19 Rapid Antibody Test Kits in both developed and developing countries, offering significant growth potential.

Challenges2 items

One of the major challenges facing the COVID-19 Rapid Antibody Test Kits market is the risk of false negative or false positive results. This can lead to inappropriate patient management and undermine trust in the tests, ultimately affecting the growth forecast of the market.

The global supply chain disruptions caused by the COVID-19 pandemic pose another challenge. These disruptions can affect the availability of raw materials, manufacturing capacity, and distribution networks, potentially limiting the COVID-19 Rapid Antibody Test Kits market size and hindering the ability of manufacturers to meet demand.

Market Segmentation

Loading chart…

The Application segment of the COVID-19 Rapid Antibody Test Kits market refers to the various uses of these kits in different settings, such as clinical and non-clinical environments. This segmentation category is crucial in understanding the COVID-19 Rapid Antibody Test Kits market size, as it highlights the diverse range of applications where these kits are utilized. The application segment contributes significantly to the overall market size, with a substantial portion of the market share attributed to the increasing demand for rapid testing in hospitals, clinics, and laboratories. Understanding the application segment is essential for market taxonomy and COVID-19 Rapid Antibody Test Kits segmentation.

The Types segment of the COVID-19 Rapid Antibody Test Kits market encompasses various subtypes, including [object Object] and [object Object]. This segmentation category provides insights into the different types of kits available, such as lateral flow assays and enzyme-linked immunosorbent assays (ELISAs). Each subtype has its unique characteristics, advantages, and limitations, contributing to the overall market size. The types segment plays a vital role in COVID-19 Rapid Antibody Test Kits segmentation, as it allows for a more detailed analysis of the market and the identification of trends and opportunities. By examining the different types of kits, manufacturers and distributors can better understand the market landscape and make informed decisions.

COVID-19 Rapid Antibody Test Kits Segmentation Breakdown10 items

Application

Hospital

Company

School

Home

Others

Types

IgG Test

IgM Test

Others

Regional Insights

Loading chart…

The COVID-19 Rapid Antibody Test Kits market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 40% of the global market, and Latin America being the fastest-growing region. Key drivers for North America include high adoption rates of COVID-19 rapid antibody test kits, favorable policies supporting the use of these kits, and significant investments in healthcare infrastructure.

In Europe, key drivers include established healthcare infrastructure, mature ecosystem for COVID-19 testing, and growing demand for rapid testing solutions. Asia Pacific is driven by large demographics, increasing investments in healthcare, and growing awareness of COVID-19 testing. Latin America is driven by growing adoption of COVID-19 rapid antibody test kits, expanding healthcare infrastructure, and increasing government initiatives to combat the pandemic. Middle East & Africa is driven by growing demand for COVID-19 testing, improving healthcare infrastructure, and increasing investments in the healthcare sector.

The regional forecast indicates that Asia Pacific will continue to dominate the COVID-19 Rapid Antibody Test Kits market, while Latin America will experience the highest growth rate. The regional analysis highlights the importance of understanding the unique characteristics of each region, including adoption rates, policies, investments, demographics, infrastructure, and ecosystem maturity, to navigate the COVID-19 Rapid Antibody Test Kits market effectively.

Competitive Landscape

The COVID-19 Rapid Antibody Test Kits market is moderately consolidated, with a mix of global players and local/regional companies driving competition. The market is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Understanding the COVID-19 Rapid Antibody Test Kits competitive landscape is crucial for companies to navigate the market effectively. Global players are focusing on expanding their distribution networks, while local companies are leveraging their regional presence to compete on pricing.

Companies in the market are adopting various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization. To stay competitive, companies must focus on technology, service model, channel strength, customization, and cost advantages. The following companies are implementing different strategies to stay ahead in the market:

RayBiotech Life: regional expansion

Aurora Biomed: innovation pipeline

SD Biosensor: OEM tie-ups

Abingdon Health: premium pricing

INSTI: local manufacturing

CTK Biotech: vertical integration

Key COVID-19 Rapid Antibody Test Kits Companies14 items

RayBiotech Life

Aurora Biomed

SD Biosensor

Abingdon Health

INSTI

CTK Biotech

SBL Testing Technologies

Biopanda

Roche Diagnostics

TestLine Clinical Diagnostics

Assay Genie

Nadal-test

Panodyne

Luminex

Market Ecosystem

The COVID-19 Rapid Antibody Test Kits ecosystem spans across upstream, midstream, and downstream segments, involving various participants who contribute to the development, production, and distribution of these test kits. Technology providers and suppliers form the upstream segment, while integrators and manufacturers constitute the midstream. The downstream segment comprises channels, such as distributors and channel partners, and end users, including healthcare professionals and patients. Value is created and captured through the interactions among these participants, ultimately leading to the delivery of COVID-19 Rapid Antibody Test Kits to end users.

Raw material/component suppliers — provide critical components

OEMs / manufacturers — produce test kits

Technology providers — develop underlying technologies

System integrators / EPCs — integrate test kits with other systems

Distributors / channel partners — distribute test kits to end users

Regulators/standards bodies — establish standards and approvals

End users / buyers — purchase and use test kits

In the COVID-19 Rapid Antibody Test Kits ecosystem, control points are primarily held by regulators and standards bodies, as they influence adoption through approvals and standards. Dependency risks arise from input constraints, such as the availability of raw materials, and standards, which can impact production and distribution. Switching costs and partnerships are also critical, as they can affect the interoperability of test kits with other systems. Furthermore, the ecosystem may differ by region due to varying regulatory requirements and market conditions, highlighting the need for a thorough value chain analysis to understand these dynamics.

Recent Industry Insights

The COVID-19 Rapid Antibody Test Kits industry trends have witnessed significant developments over the last 12-18 months, driven by the ongoing pandemic. Recent partnerships between leading diagnostic companies have focused on enhancing the accuracy and accessibility of these test kits. Notable mergers and acquisitions have also taken place, with companies aiming to expand their product portfolios and strengthen their market presence. Furthermore, several product launches have been observed, incorporating advanced technologies to improve testing efficiency and reduce turnaround times.

Additionally, regulatory changes have been implemented to ensure the quality and reliability of COVID-19 Rapid Antibody Test Kits. There has been a shift in consumer and enterprise trends, with a growing demand for rapid and accurate testing solutions. Funding rounds and expansions have also been announced, enabling companies to invest in research and development, and scale up their manufacturing capabilities to meet the increasing demand for these test kits.

Analyst Overview

As the Lead Analyst for this study, I conclude that the COVID-19 Rapid Antibody Test Kits market outlook is highly attractive due to the ongoing pandemic and the increasing demand for rapid testing solutions. The competitive intensity is moderate, with several key players dominating the market. Looking ahead, the long-term outlook is positive, driven by innovations in testing technologies and the rising need for point-of-care diagnostics.

The innovation landscape is rapidly evolving, with advancements in lateral flow assays and immunochromatography. However, the demand–supply balance remains a concern, with potential shortages and supply chain disruptions. Key risk factors include regulatory changes, market volatility, and the emergence of new variants. Overall, the COVID-19 Rapid Antibody Test Kits market is poised for growth, with opportunities for manufacturers to capitalize on the rising demand for rapid and accurate testing solutions.

12 items

1. Executive Summary

2. COVID-19 Rapid Antibody Test Kits Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global COVID-19 Rapid Antibody Test Kits Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global COVID-19 Rapid Antibody Test Kits Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global COVID-19 Rapid Antibody Test Kits Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global COVID-19 Rapid Antibody Test Kits Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global COVID-19 Rapid Antibody Test Kits Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global COVID-19 Rapid Antibody Test Kits Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global COVID-19 Rapid Antibody Test Kits Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global COVID-19 Rapid Antibody Test Kits Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global COVID-19 Rapid Antibody Test Kits Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global COVID-19 Rapid Antibody Test Kits Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global COVID-19 Rapid Antibody Test Kits Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global COVID-19 Rapid Antibody Test Kits Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global COVID-19 Rapid Antibody Test Kits Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global COVID-19 Rapid Antibody Test Kits Market Competition by Key Manufacturers

9.1. Global COVID-19 Rapid Antibody Test Kits Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global COVID-19 Rapid Antibody Test Kits: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. RayBiotech Life

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Aurora Biomed

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. SD Biosensor

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Abingdon Health

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. INSTI

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. CTK Biotech

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. SBL Testing Technologies

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Biopanda

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Roche Diagnostics

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. TestLine Clinical Diagnostics

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Assay Genie

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Nadal-test

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Panodyne

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Luminex

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global COVID-19 Rapid Antibody Test Kits Market

Figure 4: Global COVID-19 Rapid Antibody Test Kits Market: Drivers

Figure 5: Global COVID-19 Rapid Antibody Test Kits Market: Challenges

Figure 6: Global COVID-19 Rapid Antibody Test Kits Market: Trends

Figure 7: Global COVID-19 Rapid Antibody Test Kits Market: Opportunity

Figure 8: Global COVID-19 Rapid Antibody Test Kits Market: Restraint

Figure 9: Global COVID-19 Rapid Antibody Test Kits Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global COVID-19 Rapid Antibody Test Kits Market Value (USD Million) By Region

Figure 19: Global COVID-19 Rapid Antibody Test Kits Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global COVID-19 Rapid Antibody Test Kits Market Value (USD Million) By Region

Figure 27: Global COVID-19 Rapid Antibody Test Kits Market Share (%) By: Regions (2032)

Figure 28: Global COVID-19 Rapid Antibody Test Kits Market Volume (K) By Region

Figure 29: Global COVID-19 Rapid Antibody Test Kits Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global COVID-19 Rapid Antibody Test Kits Market Value (USD Million) By Region

Figure 37: Global COVID-19 Rapid Antibody Test Kits Market Share (%) By: Regions (2032)

Figure 38: Global COVID-19 Rapid Antibody Test Kits Market Volume (K) By Region

Figure 39: Global COVID-19 Rapid Antibody Test Kits Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

123 items

Table 1: Market Segmentation Analysis

Table 2: Global COVID-19 Rapid Antibody Test Kits Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global COVID-19 Rapid Antibody Test Kits Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global COVID-19 Rapid Antibody Test Kits Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global COVID-19 Rapid Antibody Test Kits Market Value (USD Million) By Region

Table 14: Global COVID-19 Rapid Antibody Test Kits Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global COVID-19 Rapid Antibody Test Kits Market Volume (K) By Region

Table 31: Global COVID-19 Rapid Antibody Test Kits Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global COVID-19 Rapid Antibody Test Kits Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global COVID-19 Rapid Antibody Test Kits Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global COVID-19 Rapid Antibody Test Kits Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: RayBiotech Life Basic Information And Sales Area

Table 52: RayBiotech Life. Products Portfolio

Table 53: Aurora Biomed Basic Information And Sales Area

Table 54: Aurora Biomed. Products Portfolio

Table 55: SD Biosensor Basic Information And Sales Area

Table 56: SD Biosensor. Products Portfolio

Table 57: Abingdon Health Basic Information And Sales Area

Table 58: Abingdon Health. Products Portfolio

Table 59: INSTI Basic Information And Sales Area

Table 60: INSTI. Products Portfolio

Table 61: CTK Biotech Basic Information And Sales Area

Table 62: CTK Biotech. Products Portfolio

Table 63: SBL Testing Technologies Basic Information And Sales Area

Table 64: SBL Testing Technologies. Products Portfolio

Table 65: Biopanda Basic Information And Sales Area

Table 66: Biopanda. Products Portfolio

Table 67: Roche Diagnostics Basic Information And Sales Area

Table 68: Roche Diagnostics. Products Portfolio

Table 69: TestLine Clinical Diagnostics Basic Information And Sales Area

Table 70: TestLine Clinical Diagnostics. Products Portfolio

Table 71: Assay Genie Basic Information And Sales Area

Table 72: Assay Genie. Products Portfolio

Table 73: Nadal-test Basic Information And Sales Area

Table 74: Nadal-test. Products Portfolio

Table 75: Panodyne Basic Information And Sales Area

Table 76: Panodyne. Products Portfolio

Table 77: Luminex Basic Information And Sales Area

Table 78: Luminex. Products Portfolio

Table 79: Global Market Value (USD Million) (2025-2032) By Application

Table 80: Global Market Share (%) By Application (2032)

Table 81: Global Market Value (USD Million) (2025-2032) By Types

Table 82: Global Market Share (%) By Types (2032)

Table 83: Global Market Volume (K) (2025-2032) By Application

Table 84: Global Market Share (%) By Application (2032)

Table 85: Global Market Volume (K) (2025-2032) By Types

Table 86: Global Market Share (%) By Types (2032)

Table 87: Global COVID-19 Rapid Antibody Test Kits Market Value (USD Million) By Region

Table 88: Global COVID-19 Rapid Antibody Test Kits Market Share (%) By Region (2025-2032)

Table 89: North America Market Value (USD Million) (2025-2032) By Country

Table 90: North America Market Value (USD Million) (2025-2032) By Application

Table 91: North America Market Value (USD Million) (2025-2032) By Types

Table 92: Europe Market Value (USD Million) (2025-2032) By Country

Table 93: Europe Market Value (USD Million) (2025-2032) By Application

Table 94: Europe Market Value (USD Million) (2025-2032) By Types

Table 95: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 96: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 97: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 98: South America Market Value (USD Million) (2025-2032) By Country

Table 99: South America Market Value (USD Million) (2025-2032) By Application

Table 100: South America Market Value (USD Million) (2025-2032) By Types

Table 101: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 102: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 103: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 104: Global COVID-19 Rapid Antibody Test Kits Market Volume (K) By Region

Table 105: Global COVID-19 Rapid Antibody Test Kits Market Share (%) By Region (2025-2032)

Table 106: North America Market Volume (K) (2025-2032) By Country

Table 107: North America Market Volume (K) (2025-2032) By Application

Table 108: North America Market Volume (K) (2025-2032) By Types

Table 109: Europe Market Volume (K) (2025-2032) By Country

Table 110: Europe Market Volume (K) (2025-2032) By Application

Table 111: Europe Market Volume (K) (2025-2032) By Types

Table 112: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 113: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 114: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 115: South America Market Volume (K) (2025-2032) By Country

Table 116: South America Market Volume (K) (2025-2032) By Application

Table 117: South America Market Volume (K) (2025-2032) By Types

Table 118: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 119: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 120: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 121: Research Programs/Design For This Report

Table 122: Key Data Information From Secondary Sources

Table 123: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

COVID-19 Rapid Antibody Test Kits Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	15.59 billion
Revenue forecast in 2033	27.19 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	RayBiotech Life; Aurora Biomed; SD Biosensor; Abingdon Health; INSTI; CTK Biotech; SBL Testing Technologies; Biopanda; Roche Diagnostics; TestLine Clinical Diagnostics; Assay Genie; Nadal-test; Panodyne; Luminex
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

COVID-19 Rapid Antibody Test Kits Segmentation Breakdown10 items

Application

Hospital

Company

School

Home

Others

Types

IgG Test

IgM Test

Others

Regional Insights

Loading chart…

Competitive Landscape

RayBiotech Life: regional expansion

Aurora Biomed: innovation pipeline

SD Biosensor: OEM tie-ups

Abingdon Health: premium pricing

INSTI: local manufacturing

CTK Biotech: vertical integration

Key COVID-19 Rapid Antibody Test Kits Companies14 items

RayBiotech Life

Aurora Biomed

SD Biosensor

Abingdon Health

INSTI

CTK Biotech

SBL Testing Technologies

Biopanda

Roche Diagnostics

TestLine Clinical Diagnostics

Assay Genie

Nadal-test

Panodyne

Luminex

Market Ecosystem

Raw material/component suppliers — provide critical components

OEMs / manufacturers — produce test kits

Technology providers — develop underlying technologies

System integrators / EPCs — integrate test kits with other systems

Distributors / channel partners — distribute test kits to end users

Regulators/standards bodies — establish standards and approvals

End users / buyers — purchase and use test kits

Recent Industry Insights

Analyst Overview

Table of Contents